Related Experiment Video

Updated: Jul 5, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

A sweet new role for EGFR in cancer

Jeffrey A Engelman1, Lewis C Cantley

  • 1Massachusetts General Hospital Cancer Center, Boston, MA 02129, USA.

Cancer Cell
|May 6, 2008
PubMed

Insights

Epidermal growth factor receptor (EGFR) aids cancer cell glucose uptake by stabilizing sodium/glucose cotransporter (SGLT1). This newly discovered function of EGFR does not require its kinase activity, revealing a novel role in cancer metabolism.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Metabolism

Background:

  • Epidermal growth factor receptor (EGFR) is a key target in cancer therapy.
  • EGFR's role as an oncogenic tyrosine kinase is well-established.
  • New research explores non-canonical functions of EGFR in cancer.

Purpose of the Study:

  • To investigate the role of EGFR in glucose transport in cancer cells.
  • To determine if EGFR's kinase activity is necessary for its role in glucose transport.
  • To elucidate a potential kinase-independent function of EGFR in cancer.

Main Methods:

  • Cellular assays to measure glucose uptake.
  • Co-immunoprecipitation to assess protein interactions between EGFR and SGLT1.
  • Western blotting to analyze protein levels and activity.
  • Experiments using EGFR kinase inhibitors and mutants.

Main Results:

  • EGFR directly associates with and stabilizes sodium/glucose cotransporter 1 (SGLT1).
  • This association facilitates increased glucose transport into cancer cells.
  • EGFR's kinase activity is not required for its role in stabilizing SGLT1 and promoting glucose uptake.
  • EGFR demonstrates a novel, kinase-independent function in regulating cellular metabolism.

Conclusions:

  • EGFR plays a significant role in cancer cell metabolism beyond its kinase activity.
  • EGFR's interaction with SGLT1 represents a new therapeutic target for modulating cancer cell energy.
  • Targeting this kinase-independent function of EGFR could offer new strategies for cancer treatment.

More Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...